{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:24:22Z","timestamp":1780853062710,"version":"3.54.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1093\/jpids\/piu032","type":"journal-article","created":{"date-parts":[[2014,5,4]],"date-time":"2014-05-04T01:04:14Z","timestamp":1399165454000},"page":"39-48","source":"Crossref","is-referenced-by-count":43,"title":["Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda"],"prefix":"10.1093","volume":"4","author":[{"given":"Paola","family":"Costenaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Penazzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Massavon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deven","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Nabachwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genny","family":"Franceschetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Bilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Musoke","family":"Nannyonga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Mastrogiacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Putoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giaquinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,5,3]]},"reference":[{"key":"key\n\t\t\t\t20170614104940_PIU032C1","article-title":"Global Report: UNAIDS Report on the Global AIDS Epidemic","author":"UNAIDS","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C2","article-title":"The Strategic Use of Antiretrovirals to Help End the HIV Epidemic","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C3","first-page":"272","article-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","author":"WHO","year":"2013"},{"key":"key\n\t\t\t\t20170614104940_PIU032C4","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/S0140-6736(12)62198-9","article-title":"Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial","volume":"381","author":"Kekitiinwa","year":"2013","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170614104940_PIU032C5","article-title":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C6","article-title":"WHO HIV Drug Resistance Report 2012","author":"WHO","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C7","article-title":"The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure [published online ahead of print September 14, 2013]","volume-title":"Trop Med Int Health","author":"Davies"},{"key":"key\n\t\t\t\t20170614104940_PIU032C8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QCO.0b013e3283423e0e","article-title":"Monitoring of highly active antiretroviral therapy in HIV infection","volume":"24","author":"Walker","year":"2011","journal-title":"Curr Opinion Infect Dis"},{"key":"key\n\t\t\t\t20170614104940_PIU032C9","article-title":"Validation of WHO 2010 Immunologic Criteria in Predicting Pediatric First-line Antiretroviral Treatment (ART) Failure in ART-experienced children in Uganda: CD4 Is a Poor Surrogate for Virologic Monitoring of Pediatric ART Failure","author":"Barlow-Mosha","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C10","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1093\/cid\/cis797","article-title":"Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe","volume":"55","author":"Walker","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"key\n\t\t\t\t20170614104940_PIU032C11","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1093\/cid\/cis006","article-title":"Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique","volume":"54","author":"Vaz","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"key\n\t\t\t\t20170614104940_PIU032C12","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1093\/infdis\/jit115","article-title":"Development of antiretroviral resistance in children with HIV in low- and middle-income countries","volume":"207","author":"Fitzgerald","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170614104940_PIU032C13","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1056\/NEJMoa1000931","article-title":"Antiretroviral treatment for children with peripartum nevirapine exposure","volume":"363","author":"Palumbo","year":"2010","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170614104940_PIU032C14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/INF.0b013e3181a458f9","article-title":"Predictors of virologic failure and genotypic resistance mutation patterns in Thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"28","author":"Jittamala","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170614104940_PIU032C15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/QAI.0b013e31814278c0","article-title":"Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy","volume":"46","author":"Kamya","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170614104940_PIU032C16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/QAI.0b013e3182060610","article-title":"Virologic failure and second-line antiretroviral therapy in children in South Africa\u2014the IeDEA Southern Africa collaboration","volume":"56","author":"Davies","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170614104940_PIU032C17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2334-12-197","article-title":"Predictors of treatment failure and time to detection and switching in HIV-infected Ethiopian children receiving first line anti-retroviral therapy","volume":"12","author":"Bacha","year":"2012","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170614104940_PIU032C18","first-page":"267","article-title":"Long-term virologic response and genotypic resistance mutations in HIV-1 infected Kenyan children on combination antiretroviral therapy","volume-title":"J Acquir Immune Defic Syndr","author":"Wamalwa","year":"2013"},{"key":"key\n\t\t\t\t20170614104940_PIU032C19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.aids.0000279711.54922.f0","article-title":"Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens","volume":"21","author":"Renaud-Thery","year":"2007","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1758-2652-13-31","article-title":"Discontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children","volume":"13","author":"Buck","year":"2010","journal-title":"J Int AIDS So"},{"key":"key\n\t\t\t\t20170614104940_PIU032C21","article-title":"WHO Consultation on ART Failure in the Context of Public Health Approach","author":"WHO","year":"2008"},{"key":"key\n\t\t\t\t20170614104940_PIU032C22","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004772.pub3","article-title":"Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age","volume-title":"Cochrane Database Syst Rev","author":"Penazzato","year":"2012"},{"key":"key\n\t\t\t\t20170614104940_PIU032C23","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa1113249","article-title":"Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children","volume":"366","author":"Violari","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170614104940_PIU032C24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1473-3099(10)70313-3","article-title":"First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2\/3 trial","volume":"11","author":"Babiker","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20170614104940_PIU032C25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e3280e087e7","article-title":"Lamivudine\/abacavir maintains virological superiority over zidovudine\/lamivudine and zidovudine\/abacavir beyond 5 years in children","volume":"21","author":"Green","year":"2007","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C26","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000000222","article-title":"Virologic response in children treated with abacavir compared with stavudine-based antiretroviral treatment: a South African multi-cohort analysis [published online ahead of print December 30, 2013]","volume-title":"Pediatr Infec Dis J","author":"Technau"},{"key":"key\n\t\t\t\t20170614104940_PIU032C27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/INF.0b013e31828c3738","article-title":"Poor early virologic performance and durability of abacavir-based first-line regimens for HIV-infected children","volume":"32","author":"Technau","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"key\n\t\t\t\t20170614104940_PIU032C28","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAD.0b013e328340fdf8","article-title":"Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysis","volume":"25","author":"Bendavid","year":"2011","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C29","doi-asserted-by":"crossref","first-page":"e1001273","DOI":"10.1371\/journal.pmed.1001273","article-title":"Treatment of young children with HIV infection: using evidence to inform policymakers","volume":"9","author":"Prendergast","year":"2012","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170614104940_PIU032C30","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1097\/QAD.0b013e32832e05b2","article-title":"Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring","volume":"23","author":"Keiser","year":"2009","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.qai.0000188123.15493.43","article-title":"Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India","volume":"41","author":"Kumarasamy","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170614104940_PIU032C32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1086\/593312","article-title":"Incidence and predictors of death, retention, and switch to second\u2010line regimens in antiretroviral\u2010treated patients in sub\u2010Saharan African sites with comprehensive monitoring availability","volume":"48","author":"Palombi","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170614104940_PIU032C33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/QAI.0b013e31805d8ae3","article-title":"Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors","volume":"45","author":"Kiguba","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170614104940_PIU032C34","doi-asserted-by":"crossref","first-page":"d6792","DOI":"10.1136\/bmj.d6792","article-title":"Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial","volume":"343","author":"Mermin","year":"2011","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170614104940_PIU032C35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00002030-200101260-00007","article-title":"Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre","volume":"15","author":"Mocroft","year":"2001","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00126334-200312010-00008","article-title":"Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort","volume":"34","author":"O'Brien","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170614104940_PIU032C37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1468-1293.2009.00750.x","article-title":"Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naive patients","volume":"11","author":"Cicconi","year":"2010","journal-title":"HIV Med"},{"key":"key\n\t\t\t\t20170614104940_PIU032C38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.antiviral.2010.03.001","article-title":"The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study","volume":"86","author":"Davidson","year":"2010","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20170614104940_PIU032C39","article-title":"Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access","author":"WHO","year":"2006"},{"key":"key\n\t\t\t\t20170614104940_PIU032C40","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1097\/QAD.0b013e32834d614c","article-title":"Early antiretroviral therapy in HIV-1-infected infants, 1996-2008: treatment response and duration of first-line regimens","volume":"25","author":"Judd","year":"2011","journal-title":"Aids"},{"key":"key\n\t\t\t\t20170614104940_PIU032C41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","article-title":"Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial","volume":"375","author":"Mugyenyi","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170614104940_PIU032C42","article-title":"HIV\/TB: A Clinical Manual. 2nd ed. Geneva","author":"WHO","year":"2004"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/4\/1\/39\/17714618\/piu032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T18:57:03Z","timestamp":1648925823000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article-lookup\/doi\/10.1093\/jpids\/piu032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,3]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,5,3]]},"published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piu032","relation":{},"ISSN":["2048-7207","2048-7193"],"issn-type":[{"value":"2048-7207","type":"electronic"},{"value":"2048-7193","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5,3]]}}}